Antimicrobial Peptides and Cationic Nanoparticles: A Broad-Spectrum Weapon to Fight Multi-Drug Resistance Not Only in Bacteria

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jun 10

PMID 35682787

Authors

Giulia E Valenti

Silvana Alfei

Debora Caviglia

Cinzia Domenicotti

Barbara Marengo

Affiliations

Soon will be listed here.

Abstract

In the last few years, antibiotic resistance and, analogously, anticancer drug resistance have increased considerably, becoming one of the main public health problems. For this reason, it is crucial to find therapeutic strategies able to counteract the onset of multi-drug resistance (MDR). In this review, a critical overview of the innovative tools available today to fight MDR is reported. In this direction, the use of membrane-disruptive peptides/peptidomimetics (MDPs), such as antimicrobial peptides (AMPs), has received particular attention, due to their high selectivity and to their limited side effects. Moreover, similarities between bacteria and cancer cells are herein reported and the hypothesis of the possible use of AMPs also in anticancer therapies is discussed. However, it is important to take into account the limitations that could negatively impact clinical application and, in particular, the need for an efficient delivery system. In this regard, the use of nanoparticles (NPs) is proposed as a potential strategy to improve therapy; moreover, among polymeric NPs, cationic ones are emerging as promising tools able to fight the onset of MDR both in bacteria and in cancer cells.

Citing Articles

Antibacterial and Antifungal Activities of Linear and Cyclic Peptides Containing Arginine, Tryptophan, and Diphenylalanine.

Salehi D, Mohammed E, Helmy N, Parang K Antibiotics (Basel). 2025; 14(1).

PMID: 39858368 PMC: 11763264. DOI: 10.3390/antibiotics14010082.

Constructing two bifunctional tooth-targeting antimicrobial peptides for caries management: an in vitro study.

Hu P, Chen P, Zhou G, Hu J, Chen S, Li Y Clin Oral Investig. 2024; 29(1):36.

PMID: 39739049 DOI: 10.1007/s00784-024-06139-7.

The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells.

Alfei S, Giannoni P, Signorello M, Torazza C, Zuccari G, Athanassopoulos C Nanomaterials (Basel). 2024; 14(18).

PMID: 39330662 PMC: 11434613. DOI: 10.3390/nano14181505.

Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway.

Nasirabadi F, Doosti A Med Oncol. 2024; 41(6):162.

PMID: 38767753 DOI: 10.1007/s12032-024-02384-8.

In vivo biodistribution and ototoxicity assessment of cationic liposomal-ceftriaxone via noninvasive trans-tympanic delivery in chinchilla models: Implications for otitis media therapy.

Shafiee S, Hong W, Lucas J, Khampang P, Runge C, Wells C Int J Pediatr Otorhinolaryngol. 2024; 178:111894.

PMID: 38350381 PMC: 10939715. DOI: 10.1016/j.ijporl.2024.111894.

References

Soucy S, Huang J, Gogarten J . Horizontal gene transfer: building the web of life. Nat Rev Genet. 2015; 16(8):472-82. DOI: 10.1038/nrg3962. View

Braunstein A, Papo N, Shai Y . In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob Agents Chemother. 2004; 48(8):3127-9. PMC: 478488. DOI: 10.1128/AAC.48.8.3127-3129.2004. View

Mookherjee N, Lippert D, Hamill P, Falsafi R, Nijnik A, Kindrachuk J . Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol. 2009; 183(4):2688-96. DOI: 10.4049/jimmunol.0802586. View

Camilio K, Berge G, Ravuri C, Rekdal O, Sveinbjornsson B . Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315. Cancer Immunol Immunother. 2014; 63(6):601-13. PMC: 4024132. DOI: 10.1007/s00262-014-1540-0. View

Tan J, Tay J, Hedrick J, Yang Y . Synthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection. Biomaterials. 2020; 252:120078. DOI: 10.1016/j.biomaterials.2020.120078. View

Cosgrove S . The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2005; 42 Suppl 2:S82-9. DOI: 10.1086/499406. View

Zhang J, Song J, Liang X, Yin Y, Zuo T, Chen D . Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance. Nanomedicine (Lond). 2019; 14(4):447-464. DOI: 10.2217/nnm-2018-0244. View

Li Y, Xu N, Zhu W, Wang L, Liu B, Zhang J . Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis. ACS Appl Mater Interfaces. 2018; 10(27):22974-22984. DOI: 10.1021/acsami.8b06125. View

Colla R, Izzotti A, Ciucis C, Fenoglio D, Ravera S, Speciale A . Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma. Oncotarget. 2016; 7(43):70715-70737. PMC: 5342585. DOI: 10.18632/oncotarget.12209. View

10.

Shang D, Zhang Q, Dong W, Liang H, Bi X . The effects of LPS on the activity of Trp-containing antimicrobial peptides against Gram-negative bacteria and endotoxin neutralization. Acta Biomater. 2016; 33:153-65. DOI: 10.1016/j.actbio.2016.01.019. View

11.

Alfei S, Piatti G, Caviglia D, Schito A . Synthesis, Characterization, and Bactericidal Activity of a 4-Ammoniumbuthylstyrene-Based Random Copolymer. Polymers (Basel). 2021; 13(7). PMC: 8038196. DOI: 10.3390/polym13071140. View

12.

Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X . Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain. J Pept Sci. 2012; 18(7):476-86. DOI: 10.1002/psc.2420. View

13.

Jeon H, Le M, Ahn B, Cho H, Le V, Yum J . Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39 with reduced mammalian cytotoxicity. Gene. 2019; 692:88-93. DOI: 10.1016/j.gene.2018.12.065. View

14.

Marengo B, Nitti M, Furfaro A, Colla R, Ciucis C, Marinari U . Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev. 2016; 2016:6235641. PMC: 4932173. DOI: 10.1155/2016/6235641. View

15.

Eun Y, Foss M, Kiekebusch D, Pauw D, Westler W, Thanbichler M . DCAP: a broad-spectrum antibiotic that targets the cytoplasmic membrane of bacteria. J Am Chem Soc. 2012; 134(28):11322-5. PMC: 3516701. DOI: 10.1021/ja302542j. View

16.

Bae S, Oh K, Kim H, Kim Y, Kim H, Hwang Y . The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion. Immunobiology. 2013; 218(8):1026-33. DOI: 10.1016/j.imbio.2012.12.002. View

17.

Alfei S, Marengo B, Zuccari G . Nanotechnology application in food packaging: A plethora of opportunities versus pending risks assessment and public concerns. Food Res Int. 2020; 137:109664. DOI: 10.1016/j.foodres.2020.109664. View

18.

Wang C, Dong S, Zhang L, Zhao Y, Huang L, Gong X . Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells. Sci Rep. 2017; 7(1):8293. PMC: 5557901. DOI: 10.1038/s41598-017-08963-2. View

19.

Lemire J, Harrison J, Turner R . Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol. 2013; 11(6):371-84. DOI: 10.1038/nrmicro3028. View

20.

Wang C, Chen T, Zhang N, Yang M, Li B, Lu X . Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha.... J Biol Chem. 2008; 284(6):3804-13. DOI: 10.1074/jbc.M807191200. View